Regulation of p53 stability by Mdm2 (original) (raw)

References

  1. Bates, S. & Vousden, K. H. p53 in signalling checkpoint arrest or apoptosis. Current Opin. Genet. Dev. 6, 1–7 (1996).
    Article Google Scholar
  2. Barak, Y. & Oren, M. Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53-mediated growth arrest. EMBO J. 11, 2115–2121 (1992).
    Article CAS Google Scholar
  3. Momand, J., Zambetti, G. P., George, D. L. & Levine, A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237–1245 (1992).
    Article CAS Google Scholar
  4. Chen, J. D., Marechal, V. & Levine, A. J. Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol. 13, 4107–4114 (1993).
    Article CAS Google Scholar
  5. Haupt, Y., Barak, Y. & Oren, M. Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J. 15, 1596–1606 (1996).
    Article CAS Google Scholar
  6. Chen, J., Wu, X., Lin, J. & Levine, A. J. mdm-2 inhibits the Gl arrest and apoptosis functions of the p53 tumor suppressor protein. Mol. Cell. Biol. 16, 2445–2452 (1996).
    Article CAS Google Scholar
  7. Barak, Y., Juven, T., Haffner, R. & Oren, M. mdm-2 expression is induced by wild type p53 activity. EMBO J. 12,461–468 (1993).
    Article CAS Google Scholar
  8. Wu, X. W., Bayle, J. H., Olson, D. & Levine, A. J. The p53 mdm-2 autoregulatory feedback loop. Genes Dev. 7, 1126–1132(1993).
    Article CAS Google Scholar
  9. Montes de Oca Luna, R., Wagner, D. S. & Lozano, G. Rescue of early embryonic lethality in _mdm2_-deficient mice by absence of p53. Nature 378, 203–206 (1995).
    Article ADS CAS Google Scholar
  10. Jones, S. N., Roe, A. E., Donehower, L. A. & Bradley, A. Rescue of embyonic lethality in Mdm2-deficient mice by absence of p53. Nature 378, 206–208 (1995).
    Article ADS CAS Google Scholar
  11. Xiao, Z.-X. et al. Interaction between the retinoblasmoma protein and the oncoprotein MDM2. Nature 375, 694–697 (1995).
    Article ADS CAS Google Scholar
  12. Martin, K. et al. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375, 691–694 (1995).
    Article ADS CAS Google Scholar
  13. Marston, N. J., Crook, T. & Vousden, K. H. Interaction of p53 with MDM2 is independent of E6 and does not mediate wild type transformation suppressor function. Oncogene 9, 2707–2716 (1994).
    CAS Google Scholar
  14. Lin, J., Chen, J., Elenbaas, B. & Levine, A. J. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev. 8, 1235–1246 (1994).
    Article CAS Google Scholar
  15. Lees-Miller, S. P., Sakaguchi, K., Ullrich, S. J., Appella, E. & Anderson, C. W. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol. Cell. Biol. 12, 5041–5049 (1992).
    Article CAS Google Scholar
  16. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J. & Howley, P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129–1136 (1990).
    Article CAS Google Scholar
  17. Hubbert, N. L., Sedman, S. A. & Schiller, J. T. Human papillomavirus type 16 E6 increases the degradatin rate of p53 in human keratinocytes. J. Virol. 66, 6237–6241 (1992).
    CAS PubMed PubMed Central Google Scholar
  18. Jones, S. N. et al. The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2. Proc. Natl Acad. Sci. USA 93, 14106–14111 (1996).
    Article ADS CAS Google Scholar
  19. Wrede, D., Tidy, J. A., Crook, T., Lane, D. & Vousden, K. H. Expression of RB and p53 proteins in HPV-positive and HPV-negative cervical carcinoma cell lines. Mol. Carcinog. 4, 171–175 (1991).
    Article CAS Google Scholar
  20. Maki, C. G., Huibregtse, J. & Howley, P. M. In vivo ubiquitination and proteosome-mediated degradation of p53. Cancer Res. 56, 2649–2654 (1996).
    CAS PubMed Google Scholar
  21. Kubbutat, M. H. G. & Vousden, K. H. Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol. Cell Biol 17, 460–468 (1997).
    Article CAS Google Scholar
  22. Fenteany, G. et al. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacytin. Science 268, 726–731 (1995).
    Article ADS CAS Google Scholar
  23. Oliner, J. D. et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362, 857–860 (1993).
    Article ADS CAS Google Scholar
  24. Haupt, Y., Maya, R., Kazaz, A. & Oren, M. Mdm2 promotes the rapid degradation of p53. Nature 387, 296–299 (1997).
    Article ADS CAS Google Scholar
  25. Di Leonardo, A., Linke, S. P., Clarkin, K. & Wahl, G. M. DNA damage triggers a prolonged p53-dependent Gl arrest and long-term induction of Cipl in normal human fibroblasts. Genes Dev. 8, 2540–2551 (1994).
    Article CAS Google Scholar
  26. Perry, M. E., Piette, J., Zawadzki, J. A., Harvey, D. & Levine, A. J. The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc. Natl Acad. Sci. USA 90, 11623–11627 (1993).
    Article ADS CAS Google Scholar
  27. Chen, C. Y. et al. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc. Natl Acad. Sci. USA 91, 2684–2688 (1994).
    Article ADS CAS Google Scholar
  28. Marston, N. J. Mutational Analysis of the Tumour Suppressor Protein p53. Thesis, Univ. London (1996).
    Google Scholar
  29. Marston, N. J., Jenkins, J. R. & Vousden, K. H. Oligomerisation of full length p53 contributes to the interaction with mdm2 but not HPV E6. Oncogene 10, 1707–1715 (1995).
    Google Scholar
  30. Rowan, S. et al. Specific loss of apoptotic but not cell cycle arrest function in a human tumour derived p53 mutant. EMBO J. 15, 827–838 (1996).
    Article CAS Google Scholar

Download references